BioTelemetry Inc. Announces CE Mark Approval of Holter Analysis Software

BioTelemetry, CE Mark, Holter analysis software

September 27, 2016 — BioTelemetry Inc. announced in late August that the company has received CE mark approval of its Holter analysis software. The software can be used either on a stand-alone basis or in combination with the company’s family of digital Holter recorders.

BioTelemetry President and CEO Joseph H. Capper said the company expects to launch an integrated solution with the newly acquired ePatch device (acquired from Delta Danish Electronics, Light & Acoustics in April) in the near future. The Holter software currently operates with BioTelemetry’s legacy Holter recorders.

The company expects to market the Holter analysis software under the Millennia brand name.

For more information: www.gobio.com

Related Content

While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.

Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

January 23, 2024

News | Cardiac Diagnostics

Wireless Handheld Ultrasound Device Launched by GE HealthCare for Rapid Assessment of Cardiac and Vascular Patients

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

September 05, 2023

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 billion by 2026. With a CAGR of 14.4% over the forecast period

Feature | Cardiac Diagnostics | By Kelly Patrick

Ambulatory Diagnostic Cardiology Market to Hit $3.3 Billion by 2026

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

May 15, 2023

Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD, have been reported by G3 Therapeutics (Global Genomics Group) and Aitia.

News | Cardiac Diagnostics

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

February 08, 2023

Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital health company designed the app to support researchers and advance the adoption of digital health technology in cardiac practice.

News | Cardiac Diagnostics

European digital health company launches app to support cardiac health

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

September 15, 2022

Feature | Cardiac Diagnostics | by Kelly Patrick

How Will the Roadmap for Diagnostic Cardiology Devices Develop?

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

August 23, 2022

. Leading the charge are devices like the Eko smart stethoscope and the Tyto remote otoscope that allow clinicians to remotely auscultate patients’ hearts, lungs and abdomen, and see inside the ear. More devices will surely come, with the aim of replicating the in-office visit.

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

The Future of Cardiac Health

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

May 04, 2022

AI system is trained to read conventional retinal scans for signs of heart disease

News | Cardiac Diagnostics

AI Can Diagnose Heart Disease By Looking In the Eye of the Patient

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

January 31, 2022

An Abbott Vascular survey found one in four physicians surveyed feel lack of technology makes an accurate diagnosis of coronary artery disease and peripheral artery disease a key obstacle to an accurate diagnosis. Getty Images

News | Cardiac Diagnostics

Research Finds Challenges in Vascular Disease Symptom Recognition and Diagnostic Testing Impacts Patient Satisfaction

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

November 10, 2021

Cardiac CT Given Strong Recommendation as Front-line Imaging of Chest Pain, but the American Society of Nuclear Cardiology (ASNC) did not support the guidelines.

Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

First International Chest Pain Diagnosis Guidelines Released

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

October 29, 2021

If you enjoy this content, please share it with a colleague

BioTelemetry Inc. Announces CE Mark Approval of Holter Analysis Software

If you enjoy this content, please share it with a colleague

Related Content